257 related articles for article (PubMed ID: 22794284)
41. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
[TBL] [Abstract][Full Text] [Related]
42. Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas.
Fangusaro J
J Child Neurol; 2009 Nov; 24(11):1409-17. PubMed ID: 19638636
[TBL] [Abstract][Full Text] [Related]
43. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
Kobayashi S; Takakura K
Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
[TBL] [Abstract][Full Text] [Related]
44. Diagnosis and management of multifocal gliomas.
Giannopoulos S; Kyritsis AP
Oncology; 2010; 79(3-4):306-12. PubMed ID: 21412017
[TBL] [Abstract][Full Text] [Related]
45. Brain tumors: current issues in diagnosis and management.
Lyons MK; Vora SA
Semin Neurol; 2007 Sep; 27(4):312-24. PubMed ID: 17701868
[TBL] [Abstract][Full Text] [Related]
46. [Management of low-grade gliomas].
Duffau H
Rev Prat; 2006 Oct; 56(16):1771-7. PubMed ID: 17315502
[TBL] [Abstract][Full Text] [Related]
47. Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th annual Frye-Halloran Brain Tumor Symposium.
Jones PS; Dunn GP; Barker FG; Curry WT; Hochberg FH; Cahill DP
Neurosurg Focus; 2013 Feb; 34(2):E9. PubMed ID: 23373454
[TBL] [Abstract][Full Text] [Related]
48. [The diagnosis and therapeutic malignant gliomas management (author's transl)].
Rougier A; Pigneux J; Richaud P; Cohadon F
Neurochirurgie; 1981; 27(5):315-20. PubMed ID: 7038524
[TBL] [Abstract][Full Text] [Related]
49. Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?
Tom MC; Cahill DP; Buckner JC; Dietrich J; Parsons MW; Yu JS
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():133-145. PubMed ID: 31099638
[TBL] [Abstract][Full Text] [Related]
50. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
Hargrave D
Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
[TBL] [Abstract][Full Text] [Related]
51. Molecular diagnostics of gliomas: the clinical perspective.
Tabatabai G; Stupp R; van den Bent MJ; Hegi ME; Tonn JC; Wick W; Weller M
Acta Neuropathol; 2010 Nov; 120(5):585-92. PubMed ID: 20862485
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
53. Contemporary management of high-grade gliomas.
Sim HW; Morgan ER; Mason WP
CNS Oncol; 2018 Jan; 7(1):51-65. PubMed ID: 29241354
[TBL] [Abstract][Full Text] [Related]
54. Radiology: criteria for determining response to treatment and recurrence of high-grade gliomas.
Lucas J; Zada G
Neurosurg Clin N Am; 2012 Apr; 23(2):269-76, viii. PubMed ID: 22440870
[TBL] [Abstract][Full Text] [Related]
55. The role of biopsy in the management of patients with presumed diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
Ragel BT; Ryken TC; Kalkanis SN; Ziu M; Cahill D; Olson JJ
J Neurooncol; 2015 Dec; 125(3):481-501. PubMed ID: 26530259
[TBL] [Abstract][Full Text] [Related]
56. Occurrence of Glioma in Pregnant Patients: An Institutional Case Series and Review of the Literature.
Singh P; Mantilla E; Sewell J; Hatanpaa KJ; Pan E
Anticancer Res; 2020 Jun; 40(6):3453-3457. PubMed ID: 32487644
[TBL] [Abstract][Full Text] [Related]
57. Response assessment challenges in clinical trials of gliomas.
Wen PY; Norden AD; Drappatz J; Quant E
Curr Oncol Rep; 2010 Jan; 12(1):68-75. PubMed ID: 20425610
[TBL] [Abstract][Full Text] [Related]
58. Grading of diffuse astrocytic gliomas: Broders, Kernohan, Zülch, the WHO… and Shakespeare.
Louis DN; von Deimling A
Acta Neuropathol; 2017 Oct; 134(4):517-520. PubMed ID: 28801693
[No Abstract] [Full Text] [Related]
59. Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatment.
Wen PY; Reardon DA
Nat Rev Neurol; 2016 Feb; 12(2):69-70. PubMed ID: 26782337
[No Abstract] [Full Text] [Related]
60. Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.
Ramkissoon LA; Britt N; Guevara A; Whitt E; Severson E; Sathyan P; Gay L; Elvin J; Ross JS; Brown C; Stogner-Underwood K; Mott R; Kram D; Strowd R; Lesser GJ; Ramkissoon SH
Curr Treat Options Oncol; 2018 Jun; 19(8):41. PubMed ID: 29931654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
